SE7608115L - Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan

Info

Publication number
SE7608115L
SE7608115L SE7608115A SE7608115A SE7608115L SE 7608115 L SE7608115 L SE 7608115L SE 7608115 A SE7608115 A SE 7608115A SE 7608115 A SE7608115 A SE 7608115A SE 7608115 L SE7608115 L SE 7608115L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
therapeutic effect
kinoxalin
derivatives
Prior art date
Application number
SE7608115A
Other languages
English (en)
Other versions
SE423814B (sv
Inventor
J B Cambell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7608115L publication Critical patent/SE7608115L/sv
Publication of SE423814B publication Critical patent/SE423814B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7608115A 1975-07-16 1976-07-15 Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat SE423814B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,543 US4024142A (en) 1975-07-16 1975-07-16 Quinoxaline derivatives as immune regulants

Publications (2)

Publication Number Publication Date
SE7608115L true SE7608115L (sv) 1977-01-17
SE423814B SE423814B (sv) 1982-06-07

Family

ID=24387731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608115A SE423814B (sv) 1975-07-16 1976-07-15 Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat

Country Status (30)

Country Link
US (2) US4024142A (sv)
JP (1) JPS5212181A (sv)
AR (1) AR213409A1 (sv)
AT (1) AT351032B (sv)
AU (1) AU498254B2 (sv)
BE (1) BE844084A (sv)
BG (2) BG26668A4 (sv)
CA (1) CA1057289A (sv)
CH (1) CH621779A5 (sv)
CS (1) CS189016B2 (sv)
DD (1) DD126751A5 (sv)
DE (1) DE2631888A1 (sv)
DK (1) DK142872B (sv)
FR (1) FR2317931A1 (sv)
GB (1) GB1550467A (sv)
GR (1) GR62257B (sv)
HU (1) HU172133B (sv)
IE (1) IE43242B1 (sv)
IL (1) IL49880A (sv)
MX (1) MX3387E (sv)
NL (1) NL7607882A (sv)
NZ (1) NZ181248A (sv)
PH (1) PH12095A (sv)
PL (1) PL100501B1 (sv)
PT (1) PT65343B (sv)
RO (1) RO72510A (sv)
SE (1) SE423814B (sv)
SU (1) SU674673A3 (sv)
YU (1) YU160576A (sv)
ZA (1) ZA763764B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60130541A (ja) * 1983-12-15 1985-07-12 Sumitomo Chem Co Ltd メチルフエノ−ルの製造方法
JPS62240637A (ja) * 1986-04-11 1987-10-21 Maruzen Petrochem Co Ltd フエノ−ル類のアルキル化方法
WO2008089283A1 (en) * 2007-01-16 2008-07-24 Jj Pharma, Inc. Phenazine compounds and use thereof in autoimmune and inflammatory diseases
US8336289B2 (en) * 2007-08-30 2012-12-25 United Technologies Corporation Gas turbine engine systems and related methods involving multiple gas turbine cores
WO2012054739A2 (en) * 2010-10-21 2012-04-26 New York University Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2046254A (en) * 1932-06-14 1936-06-30 Gen Aniline Works Inc Vat dyestuffs derived from aceanthrenequinone and process of preparing them
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3481931A (en) * 1965-06-01 1969-12-02 Donald L Vivian Acenaphtho(1,2-b)quinoxaline,7,12-dioxide

Also Published As

Publication number Publication date
ZA763764B (en) 1978-02-22
CA1057289A (en) 1979-06-26
SE423814B (sv) 1982-06-07
DK142872C (sv) 1981-09-21
PH12095A (en) 1978-10-30
IL49880A (en) 1979-10-31
AR213409A1 (es) 1979-01-31
ATA517476A (de) 1978-12-15
PT65343A (en) 1976-08-01
FR2317931B1 (sv) 1981-11-27
AU498254B2 (en) 1979-02-22
BG26668A4 (sv) 1979-05-15
BE844084A (fr) 1977-01-14
HU172133B (hu) 1978-06-28
GR62257B (en) 1979-03-19
RO72510A (ro) 1982-09-09
YU160576A (en) 1982-05-31
AT351032B (de) 1979-07-10
US4064127A (en) 1977-12-20
FR2317931A1 (fr) 1977-02-11
CH621779A5 (sv) 1981-02-27
CS189016B2 (en) 1979-03-30
PL100501B1 (pl) 1978-10-31
IL49880A0 (en) 1976-08-31
DE2631888A1 (de) 1977-02-03
DK320576A (sv) 1977-01-17
NZ181248A (en) 1978-09-20
JPS5212181A (en) 1977-01-29
DK142872B (da) 1981-02-16
MX3387E (es) 1980-10-27
SU674673A3 (ru) 1979-07-15
BG25646A3 (sv) 1978-11-10
IE43242B1 (en) 1981-01-14
US4024142A (en) 1977-05-17
IE43242L (en) 1977-01-16
AU1525676A (en) 1978-01-05
DD126751A5 (sv) 1977-08-10
PT65343B (en) 1979-03-09
NL7607882A (nl) 1977-01-18
GB1550467A (en) 1979-08-15

Similar Documents

Publication Publication Date Title
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE423544B (sv) Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE414633B (sv) Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan
SE411119B (sv) Analogiforfarande for framstellning av l-indolin-l-yl-guanidinderivat med terapeutisk verkan
SE417712B (sv) Forfarande for framstellning av n-(6-acyloxibensotiazol-2-yl)-nŸ-fenylkarbamider med terapeutisk verkan
SE7606236L (sv) Forfarande for framstellning av piperazinforeningar med terapeutisk verkan
SE7708521L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE7507566L (sv) Forfarande for framstellning av etylbensenderivat med terapeutisk verkan
SE408058B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE7701551L (sv) Forfarande for framstellning av bensenkarboxamidderivat med terapeutisk verkan
SE7604861L (sv) Forfarande for framstellning av bensobicyklononenderivat
SE7601247L (sv) Forfarande for framstellning av tienopyridinderivat